Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Corneal Neovascularization D016510 8 associated lipids
Lupus Nephritis D008181 8 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Leukopenia D007970 9 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Immune Complex Diseases D007105 9 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Eche N et al. Platelet aggregating and procoagulant activities of cultured human breast cancer cells (FAM). 1986 Thromb. Res. pmid:3726808
Hoffman DR et al. The role of platelet-activating factor in human fetal lung maturation. 1986 Am. J. Obstet. Gynecol. pmid:3728606
Valone FH and Ruis NM Platelet-activating factor binding to human platelet membranes. 1986 Biotechnol. Appl. Biochem. pmid:3021183
Naccache PH et al. Biochemical events associated with the stimulation of rabbit neutrophils by platelet-activating factor. 1986 J. Leukoc. Biol. pmid:3021882
Sugatani J and Hanahan DJ Characterization of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (AGEPC)-induced protein phosphorylation in rabbit platelets: inhibitory effects of AGEPC analogs. 1986 Arch. Biochem. Biophys. pmid:3754710
Hsueh W et al. Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists. 1986 Eur. J. Pharmacol. pmid:3754817
Okamoto M et al. Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF. 1986 Thromb. Res. pmid:3754990
Schlondorff D and Neuwirth R Platelet-activating factor and the kidney. 1986 Am. J. Physiol. pmid:3089026
Oh-ishi S et al. Suppression of phorbol myristate acetate-induced pleurisy by CV-3988, an antagonist of platelet-activating factor. 1986 Chem. Pharm. Bull. pmid:3829203
Viero P et al. Thrombotic thrombocytopenic purpura and high-dose immunoglobulin treatment. 1986 Ann. Intern. Med. pmid:3946966
Ramesha CS and Pickett WC Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry. 1986 Biomed. Environ. Mass Spectrom. pmid:2938649
Siafaka-Kapadai A et al. Biological activity of lipids of pine pollen on platelet aggregation in correlation with the platelet activating factor. 1986 Biochem. Int. pmid:3947373
McNamara PJ et al. Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG). 1986 Biochem. Pharmacol. pmid:3947392
Resink TJ et al. The influence of activating hormones on human platelet membrane Ca2+-ATPase activity. 1986 Biochem. Biophys. Res. Commun. pmid:2943273
Gay JC et al. Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor. 1986 Blood pmid:3006836
Davis RB and Johnson MF Effects of bacterial endotoxin and platelet activating factor (PAF) on human platelet aggregation in native whole blood. 1986 Thromb. Res. pmid:3544327
Piper PJ and Stewart AG Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4. 1986 Br. J. Pharmacol. pmid:3091131
Foegh ML et al. Fatty acids and eicosanoids in organ transplantation. 1986 Prog. Lipid Res. pmid:3321095
Kohayakawa M and Inoue K Augmentation of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF)-induced human platelet activation by C-reactive protein. 1986 Thromb. Res. pmid:3083530
Morley J et al. Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis. 1986 Ann Allergy pmid:3083731
McIntosh TK and Faden AI Thyrotropin-releasing hormone (TRH) and circulatory shock. 1986 Circ. Shock pmid:3084122
Ghezzi E Autacoids and some mediators in allergic and non allergic forms. 1986 Boll Ist Sieroter Milan pmid:2877678
Raphael GD and Metcalfe DD Mediators of airway inflammation. 1986 Eur J Respir Dis Suppl pmid:2429857
Hsueh W et al. Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor. 1986 J. Clin. Invest. pmid:3459734
Bessin P PAF-acether and leukotriene participation in acute circulatory shock. 1986 Pharmacol Res Commun pmid:3774841
Goldstein RE et al. Coronary and pulmonary vascular effects of leukotrienes and PAF-acether. 1986 Pharmacol Res Commun pmid:3774842
Plante GE et al. Hemodynamic effects of PAF-acether. 1986 Pharmacol Res Commun pmid:3774843
Thomas Y et al. [Synthesis of paf-acether by E. coli K12]. 1986 C. R. Acad. Sci. III, Sci. Vie pmid:3101984
Rosam AC et al. Potent ulcerogenic actions of platelet-activating factor on the stomach. 1986 Jan 2-8 Nature pmid:3510396
Kako KJ Membrane phospholipids and plasmalogens in the ischemic myocardium. 1986 May-Jun Can J Cardiol pmid:2424580
von Tscharner V et al. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. 1986 Nov 27-Dec 3 Nature pmid:2431318
Benhamou M and Mencia-Huerta JM Effect of glucocorticosteroids on the expression of Fc epsilon R1 and on mediator release from mast cells. 1986 Sep-Oct Ann. Inst. Pasteur Immunol. pmid:2948525
Morley J Theophylline in asthma. 1986 Sep-Oct Bull Eur Physiopathol Respir pmid:3801711
Sugiyama T et al. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. 1987 Blood pmid:3580576
Bussolino F et al. Chick retina generates platelet-activating factor. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2890284
Mikashima H et al. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding. 1987 Jpn. J. Pharmacol. pmid:2890779
Gautheron PD et al. A study of PAF-induced ocular inflammation in the rat and its inhibition by the PAF antagonist, L-652,731. 1987 J. Pharm. Pharmacol. pmid:2891830
McFall TL et al. Effect of group B streptococcal type-specific antigen on polymorphonuclear leukocyte function and polymorphonuclear leukocyte-endothelial cell interaction. 1987 Pediatr. Res. pmid:3037472
Kornecki E et al. Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines. 1987 Adv. Exp. Med. Biol. pmid:2893525
Kumar R et al. Metabolism of platelet-activating factor (alkylacetylphosphocholine) by type-II epithelial cells and fibroblasts from rat lungs. 1987 Biochim. Biophys. Acta pmid:3790610
Abstracts of the meeting: The role of platelet-activating factors in the immune response. Paris, France, June 25 and 26, 1987. 1987 Prostaglandins pmid:3671731
Bourgain RH et al. Arterial obstruction induced by PAF-acether (1-O-alkyl-sn-glycero-3-phosphocholine). 1987 Adv. Exp. Med. Biol. pmid:3673721
Myers AK and Bader TJ Role of adrenal steroids in the recovery from platelet activating factor challenge. 1987 Circ. Shock pmid:3677334
Hsueh W et al. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. 1987 FASEB J. pmid:3678700
Terasawa M et al. Antagonistic activity of etizolam on platelet-activating factor in vivo experiments. 1987 Jpn. J. Pharmacol. pmid:3682404
Sipka S et al. Atropine is an inhibitor of the chemiluminescence induced by platelet-activating factor in human neutrophils. 1987 Acta Biochim. Biophys. Hung. pmid:3132002
Bittman R et al. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone. 1987 J. Lipid Res. pmid:3611974
Terashita Z et al. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. 1987 J. Pharmacol. Exp. Ther. pmid:3612533
Levy JV Spasmogenic effect of platelet activating factor (PAF) on isolated rat stomach fundus strip. 1987 Biochem. Biophys. Res. Commun. pmid:3619905
Huber M and Keppler D Inhibition of leukotriene D4 catabolism by D-penicillamine. 1987 Eur. J. Biochem. pmid:3622511
Egido J et al. Role of platelet-activating factor in adriamycin-induced nephropathy in rats. 1987 Eur. J. Pharmacol. pmid:3622604
Kawaguchi H and Yasuda H Effects of platelet-activating factor on conversion of angiotensin I to II. 1987 FEBS Lett. pmid:3622769
Ninio E et al. Biosynthesis of paf-acether. IX. Role for a phosphorylation-dependent activation of acetyltransferase in antigen-stimulated mouse mast cells. 1987 J. Immunol. pmid:3584983
Sha'afi RI and Molski TF Signalling for increased cytoskeletal actin in neutrophils. 1987 Biochem. Biophys. Res. Commun. pmid:3036146
Feuerstein G et al. Protective effect of a PAF-acether antagonist, BN 52021, in trichothecene toxicosis. 1987 Toxicol. Lett. pmid:3660430
Heinsohn C et al. The effect of bovine serum albumin on the synthesis of prostaglandin and incorporation of [3H]acetate into platelet-activating factor. 1987 Arch. Biochem. Biophys. pmid:3662526
Sperling RI et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. 1987 Arthritis Rheum. pmid:3663263
Siess W and Lapetina EG Phorbol esters sensitize platelets to activation by physiological agonists. 1987 Blood pmid:3663938
Casals-Stenzel J et al. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist. 1987 Br. J. Pharmacol. pmid:3664079
Robertson DN and Page CP Effect of platelet agonists on airway reactivity and intrathoracic platelet accumulation. 1987 Br. J. Pharmacol. pmid:3664082
Whittle BJ et al. Increased intestinal formation of Paf in endotoxin-induced damage in the rat. 1987 Br. J. Pharmacol. pmid:3664090
Homma H et al. Some unique features of the metabolic conversion of platelet-activating factor (AGEPC) to alkyl acyl PC by washed rabbit platelets. 1987 Arch. Biochem. Biophys. pmid:3101596
Takahashi H et al. [Blood coagulation disorders in thrombotic thrombocytopenic purpura--with special reference to a von Willebrand factor abnormality]. 1987 Rinsho Byori pmid:3501812
Haroldsen PE et al. Metabolism of platelet-activating factor in isolated perfused rat lung. 1987 J. Clin. Invest. pmid:3108322
Tahara T et al. PAF antagonistic activity of some thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines. 1987 Chem. Pharm. Bull. pmid:3664818
Haroldsen PE et al. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry. 1987 J. Lipid Res. pmid:3104521
Bienenstock J et al. Mast cell involvement in various inflammatory processes. 1987 Am. Rev. Respir. Dis. pmid:3109295
O'Neill C Embryo-derived platelet activating factor: a preimplantation embryo mediator of maternal recognition of pregnancy. 1987 Domest. Anim. Endocrinol. pmid:3333935
Teng CM et al. Antiplatelet effect of butylidenephthalide. 1987 Biochim. Biophys. Acta pmid:3109495
Whatley RE et al. Production of platelet-activating factor by endothelial cells. 1987 Semin. Thromb. Hemost. pmid:3321437
Kelton JG and Murphy WG Acute thrombocytopenia and thrombosis. Heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura. 1987 Ann. N. Y. Acad. Sci. pmid:3322132
Valone FH and Johnson B Modulation of platelet-activating-factor-induced calcium influx and intracellular calcium release in platelets by phorbol esters. 1987 Biochem. J. pmid:3322269
Tou JS Platelet-activating factor modulates phospholipid acylation in human neutrophils. 1987 Lipids pmid:3110533
Chen DC [Phosphoinositide metabolism and platelet activation]. 1987 Sheng Li Ke Xue Jin Zhan pmid:2838899
Kawamura Y et al. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions]. 1987 Rinsho Byori pmid:3437547
Kertscher HP and Ostermann G [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group]. 1987 Pharmazie pmid:3438334
Riedel A et al. The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity. 1987 Pharmacol Res Commun pmid:3441484
Bussolino F et al. Intravascular release of platelet activating factor in children with sepsis. 1987 Thromb. Res. pmid:3441909
Bossant MJ et al. Characterization and quantification of PAF-acether (platelet-activating factor) as a heptafluorobutyrate derivative of 1-O-alkyl-2-acetyl-sn-glycerol by capillary column gas chromatography with electron-capture detection. 1987 J. Chromatogr. pmid:3443654
Parker CW Lipid mediators produced through the lipoxygenase pathway. 1987 Annu. Rev. Immunol. pmid:3036183
Shimizu K et al. [Actions of platelet activating factor in pulmonary circulation--experimental investigation using rabbit blood vessel smooth muscle preparations]. 1987 Nihon Kyobu Shikkan Gakkai Zasshi pmid:3444152
Leff AR et al. Parasympathetic involvement in PAF-induced contraction in canine trachealis in vivo. 1987 J. Appl. Physiol. pmid:2881917
Feuerstein G and Hallenbeck JM Prostaglandins, leukotrienes, and platelet-activating factor in shock. 1987 Annu. Rev. Pharmacol. Toxicol. pmid:3034139
Khandwala A et al. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release. 1987 Biochem. Pharmacol. pmid:2435293
Alloatti G et al. Protective effect of verapamil on the cardiac and circulatory alterations induced by platelet-activating factor. 1987 J. Cardiovasc. Pharmacol. pmid:2435996
Kappa JR et al. Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374). 1987 J. Vasc. Surg. pmid:2437338
Serafin WE and Austen KF Mediators of immediate hypersensitivity reactions. 1987 N. Engl. J. Med. pmid:2438554
Avdonin PV et al. Evidence for the receptor-operated calcium channels in human platelet plasma membrane. 1987 Thromb. Res. pmid:2438805
Sperling RI et al. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. 1987 J. Immunol. pmid:2826583
de Arriba G et al. Changes in glomerular cross-sectional area induced by platelet activating factor. 1987 Nephrol. Dial. Transplant. pmid:3118261
Darius H and Lefer AM Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis. 1987 Prog. Clin. Biol. Res. pmid:3118384
Michel L et al. Biologic properties of LTB4 and paf-acether in vivo in human skin. 1987 J. Invest. Dermatol. pmid:3035030
Shalit M et al. Platelet-activating factor both stimulates and "primes" human polymorphonuclear leukocyte actin filament assembly. 1987 Blood pmid:3118991
Touqui L et al. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets. 1987 Biochem. J. pmid:3109377
Sheth KJ et al. Reversal of central nervous system involvement in hemolytic uremic syndrome by use of plasma exchanges. 1987 Clin Pediatr (Phila) pmid:3119270
Bureau M et al. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether. 1987 Prostaglandins pmid:3035615
Sage SO and Rink TJ The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets. 1987 J. Biol. Chem. pmid:3119586
Camussi G et al. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. 1987 J. Exp. Med. pmid:3119758
Satouchi K et al. 1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes. 1987 Lipids pmid:3110532
Di Marzo V et al. Neuropeptides and leukotriene release: effect of peptide histidine isoleucine and secretin in platelet activating factor-stimulated rat lung. 1987 Neuropeptides pmid:3031537